Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$13.05 - $33.93 $3.26 Million - $8.48 Million
-250,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$12.71 - $16.5 $3.18 Million - $4.13 Million
250,000 New
250,000 $3.18 Million

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About GRAYBUG VISION, INC.


  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.